Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQFinancialsInsurance - Property & CasualtySnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
stable leadership and execution | A supporting condition in NI Holdings, Inc.'s published investment case. The stated target is no further CEO or key director departures. | Intact | CEO or key director departures occur | 0 CEO departures vs 0 allowed News feed shows routine earnings and board elections. No adverse executive departures detected. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 6, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is an insurance turnaround case, not yet a proven durable compounder. The long-term thesis is in a watch state: underwriting measures have improved, but recent financial performance remains weak relative to its industry cohort.
NODK is described as cheap versus peers, while the overall expectations gap is modest and the priced-in tag is stretched. That points to some room for doubt in expectations, but does not remove the risk that weak execution and elevated business risk matter more than the peer discount.
Near-term results may remain uneven as the strategic exit from Non-Standard Auto reduces premiums, while the combined ratio has improved with favorable reserve development and lower losses. Management has shown progress on operational performance, but earnings quality is neutral and the business remains loss-making overall.
Over the next few quarters, the key test is whether underwriting profitability improves without further weakening the core business as premiums decline. The broader sector backdrop also matters: rate cuts could be a headwind, while continued strong results from insurance bellwethers could support sector momentum; misses or weaker guidance could remove that support.
For a 1-to-3-year view, NODK offers a potentially improving underwriting story, but the evidence is mixed and the recent financial record remains weak. The thesis depends on sustained operating progress and a less adverse sector backdrop. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in NI Holdings, Inc.'s published investment case. The stated target is free cash flow yield improves toward 0% or positive. |
| Broken |
| free cash flow yield remains below -8% or worsens |
Free cash flow yield: -10.55% As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 2026-10.55 percent · calculatedLast status assessment Oct 24, 2026Measurement sourceconsolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: NODK:2026-10-23. Source status: canonical calculation. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
revenue decline limited to no worse than -13% next year | Analysts expect revenue to decline about 13% next year, reflecting challenges but also potential for recovery. | Intact | YoY revenue growth falls below -13% next year | Revenue growth: -7.66% FY2026-Q2; GAAP. Published target: >= -13% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Aug 7, 2026-7.6561 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: d76dfd54-22dd-4429-94dc-d6e4b3740e45. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.